Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Gudmundsdottir, Brynja R
Larsen, Ole H
Onundarson, Pall T
MetadataShow full item record
CitationPlatelets 2014, 25 (5):357-62
AbstractWomen with Bernard-Soulier syndrome (BSS) are considered to be at high risk of serious bleeding during childbirth. Due to the frequently occurring platelet transfusion refractoriness, alternative prophylactic therapy is required. Using rotational thromboelastometry, we evaluated the whole blood coagulation profile of a pregnant woman with BSS before and after spiking ex vivo with different concentrations of recombinant activated factor VII (rFVIIa) and fibrinogen. As experiments suggested improved clotting with clinically applicable concentrations of both agents in a complementary manner, the findings were confirmed on blood from a non-pregnant woman and three men suffering from BSS. During delivery, bleeding refractory to platelets occurred and immediately following delivery she received both rFVIIa and fibrinogen intravenously. Immediate cessation of bleeding occurred, and no postpartum hemorrhage was seen. Another woman with BSS later also received the same rFVIIa and fibrinogen treatment prophylactically after delivery without any postpartum bleeding. Eventually, the first woman during her second delivery received the same treatment again prophylactically without any bleeding. No side effects were observed during these three deliveries. Our observations suggest that rFVIIa combined with fibrinogen may provide a beneficial clinical hemostatic effect partly by separate but complementary mechanisms.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
RightsArchived with thanks to Platelets
- Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
- Authors: Ozelo MC, Svirin P, Larina L
- Issue date: 2005 Nov
- [Obstetric and gynecological intervention in women with Bernard-Soulier syndrome: report of two cases].
- Authors: Mitrović M, Elezović I, Miljić P, Antić D
- Issue date: 2014 May-Jun
- Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
- Authors: Tefre KL, Ingerslev J, Sørensen B
- Issue date: 2009 Jan
- The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
- Authors: Sørensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT
- Issue date: 2009 Dec
- Bernard-Soulier syndrome in pregnancy.
- Authors: Prabu P, Parapia LA
- Issue date: 2006 Jun